Skip to Content
The Pieper Laboratory focuses on the discovery of new treatment options for neuropsychiatric disease using pharamcologic approaches in animal models. This approach is characterized by the discovery of the P7C3-series of neuroprotective molecules, which offer mitchondrial protection in many preclinical models of neurodegeneration. The Pieper Laboratory is also investigating new treatment approaches for autism, anxiety, and obsessive compulsive disorder.
Andrew Pieper, MD, PhD, professional profile